Article

PDF
Access to the PDF text
Service d'aide à la décision clinique
Advertising



Journal Français d'Ophtalmologie
Volume 35, n° 4
pages 260-265 (avril 2012)
Doi : 10.1016/j.jfo.2011.07.006
Received : 2 February 2010 ;  accepted : 17 June 2011
Utilisation du bévacizumab (Avastin®) en injection intravitréenne avant vitrectomie pour rétinopathie diabétique sévère, à propos de six cas
Intravitreal bevacizumab pretreatment in vitrectomy for severe diabetic retinopathy: A series of six cases
 

Figure 1




Figure 1 : 

Dissection de la prolifération fibrovasculaire à l’aide de ciseaux droits.


Figure 2




Figure 2 : 

Pelage de la prolifération fibrovasculaire à la pince en exerçant une traction parallèle à la rétine.


Figure 3




Figure 3 : 

Régression rapide des néovaisseaux (B. flèche) le lendemain d’une injection intravitréenne de bévacizumab à la dose de 2,5mg sur un décollement de rétine tractionnel.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline